Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Pricing Report NDC 46122-452-60

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 46122-452-60) is $0.61082 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 19, 2021.

As a a human over the counter drug provided by Amerisource Bergen, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.61082
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
May 19, 2021
Billable Units
1 EA
Estimated Package Price
$0.61
Data Status
As of May 26, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
46122-452-60
Description
1 BLISTER PACK in 1 CARTON / 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2020, the NADAC wholesale price for (NDC ) has moved within a range of $0.48295 to $0.62711 per EA. Over this 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4830 - $0.6271
Market Volatility
29.85% Variance
Latest Trend
26.48%
Date Unit Price Unit Source Method Rate
May 19, 2021 $0.61082 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 21, 2021 $0.48295 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 17, 2021 $0.52155 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 17, 2021 $0.54207 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 20, 2021 $0.53456 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 23, 2020 $0.62711 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 18, 2020 $0.54208 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Oct 21, 2020 $0.51922 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Sep 23, 2020 $0.57228 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 19, 2020 $0.51695 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2020 $0.59108 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026